Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by RADIUS ADVOCACY, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-01 06:26:09 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$30,000.00
Expenses
Not reported
Filing UUID
5c01aa04-6a56-48f8-b44f-ed38f7609792
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

CPT · Copyright/Patent/Trademark

Patent rights. Merchant rights. S.1097 - Interagency Patent Coordination and Improvement Act of 2025.

Literal federal measure citations: S.1097

PHA · Pharmacy

Issues related to competition pracitces in the pharmaceutical marketplace. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.2658 - Medication Affordability and Patent Integrity Act (MAPIA). S.1095 - Stop STALLING Act. S.43 - Skinny Labels, Big Savings Act.

Literal federal measure citations: S.1040, S.1041, S.2658, S.1095, S.43

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.